Skip to main content
SpringerLink
Log in

Adolescents with Medical Illness

  • Chapter
  • First Online:
Book cover Contraception for Adolescent and Young Adult Women

  • 1074 Accesses

Abstract

Ensuring that pregnancies are anticipated and intended is particularly important for young women with medical illness. Many chronic diseases heighten the risk for adverse obstetrical and birth outcomes, while pregnancy may also exacerbate illness severity. This chapter covers contraceptive management in illnesses that are either commonly encountered among adolescents and young women or that are of such medical significance that they have great clinical and social impact on a young woman’s daily life, particularly in the setting of pregnancy. We provide an overview of the adolescent and young adult epidemiology of and recommended and contraindicated contraceptive methods for the following illnesses: asthma, history of bariatric surgery, cardiac anomalies, cystic fibrosis, deep vein thrombosis risk factors, diabetes, depression, disordered eating, epilepsy, headache disease (including tension and migraine), hypertension, inflammatory bowel disease, liver disease, sickle cell disease, systemic lupus erythematosus, and von Willebrand disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Centers for Disease Control and Prevention. U.S. medical eligibility criteria for contraceptive use, 2010. MMWR. 2010;59(RR-4):i-85.

    Google Scholar 

  2. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.

    Google Scholar 

  3. Akinbami LJ, Moorman JE, Liu X. Asthma prevalence, health care use, and mortality: United States, 2005–2009. National health statistics reports; no 32. Hyattsville, MD: National Center for Health Statistics; 2011.

    Google Scholar 

  4. D’Angelo D, Williams L, Morrow B, Cox S, Harris N, Harrison L. Preconception and interconception health status of women who recently gave birth to a live-born infant—Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004. MMWR Surveill Summ. 2007;56(10):1–35. Erratum in: MMWR Morb Mortal Wkly Rep. 2008;57(16):436.

    Google Scholar 

  5. American College of Obstetricians and Gynecologists. Asthma in pregnancy, ACOG practice bulletin no. 90. Obstet Gynecol. 2008;111(2 Pt 1):457–64.

    Google Scholar 

  6. Schatz M, Dombrowski MP, Wise R, Momirova V, Landon M, Mabie W, et al. Spirometry is related to perinatal outcomes in pregnant women with asthma. Am J Obstet Gynecol. 2006;194(1):120–6.

    Article  PubMed  Google Scholar 

  7. Tan KS. Premenstrual asthma: epidemiology, pathogenesis and treatment. Drugs. 2001;61(14):2079–86.

    Article  CAS  PubMed  Google Scholar 

  8. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation patient registry 2010 annual data report. Bethesda, MD: Cystic Fibrosis Foundation; 2012.

    Google Scholar 

  9. Tsang A, Moriarty C, Towns S. Contraception, communication and counseling for sexuality and reproductive health in adolescents and young adults with CF. Paediatr Respir Rev. 2010;11:84–9.

    Article  PubMed  Google Scholar 

  10. Plant BJ, Goss CH, Tonelli MR, McDonald G, Black RA, Aitken ML. Contraceptive practices in women with cystic fibrosis. J Cyst Fibros. 2008;7(5):412–4.

    Article  PubMed  Google Scholar 

  11. Sawyer SM, Phelan PD, Bowes G. Reproductive health in young women with cystic fibrosis: knowledge, behavior and attitudes. J Adolesc Health. 1995;17(1):46–50.

    Article  CAS  PubMed  Google Scholar 

  12. Townsend EA, Miller VM, Prakash YS. Sex differences and sex steroids in lung health and disease. Endocr Rev. 2012;33(1):1–47.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Simcox AM, Duff AJ, Morton AM, Edenborough FP, Conway SP, Hewison J. Decision making about reproduction and pregnancy by women with cystic fibrosis. Br J Hosp Med. 2009;70(11):639–43.

    Article  CAS  Google Scholar 

  14. Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004–2006. Birth Defects Res A Clin Mol Teratol. 2010;88(12):1008–16.

    Article  CAS  PubMed  Google Scholar 

  15. Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and blood vessels. Boston: Little Brown; 1964.

    Google Scholar 

  16. Sui SC, Sermer M, Colman JM, Alvarez AN, Mercier L, Morton BC. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104:515–21.

    Article  Google Scholar 

  17. Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart. 2006;92:1520–5.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Nishimura RA, Carabello BA, Faxon DP, Freed MD, Lytle BW, O’Gara PT, et al. ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(8):676–85.

    Article  PubMed  Google Scholar 

  19. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736–54.

    Article  PubMed  Google Scholar 

  20. Berenson AB, Rahman M, Wilkinson G. Effect of injectable and oral contraceptives on serum lipids. Obstet Gynecol. 2009;114(4):786–94.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Kongsayreepong R, Chutivongse S, George P, Joyce S, McCone JM, Garza-Flores J, et al. A multicentre comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD users. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction. Contraception. 1993;47(2):177–91.

    Article  CAS  PubMed  Google Scholar 

  22. Curtis KM, Mohllajee AP, Martins SL, Peterson HB. Combined oral contraceptive use among women with hypertension: a systematic review. Contraception. 2006;73(2):179–88.

    Article  CAS  PubMed  Google Scholar 

  23. Pollara T, Kelsberg G, Safranek S, Schrager S. Clinical inquiries. What is the risk of adverse outcomes in a woman who develops mild hypertension from OCs? J Fam Pract. 2006;55(11):986–8.

    PubMed  Google Scholar 

  24. Lubianca JN, Moreira LB, Gus M, Fuchs FD. Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension. J Hum Hypertens. 2005;19:451–5.

    Article  CAS  PubMed  Google Scholar 

  25. Russ SA, Larson K, Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics. 2012;129(2):256–64.

    Article  PubMed  Google Scholar 

  26. Adab N, Tudur Smith C, Vinten J, Williamson PR, Winterbottom JB. Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Syst Rev. 2004;(3):CD004848.

    Google Scholar 

  27. Banach R, Boskovic R, Einarson T, Koren G. Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studies. Drug Saf. 2010;33(1):73–9.

    Article  CAS  PubMed  Google Scholar 

  28. Herzog AG. Catamenial epilepsy: definition, prevalence pathophysiology and treatment. Seizure. 2008;17(2):151–9.

    Article  PubMed  Google Scholar 

  29. Verrotti A, Laus M, Coppola G, Parisi P, Mohn A, Chiarelli F. Catamenial epilepsy: hormonal aspects. Gynecol Endocrinol. 2010;26(11):783–90.

    Article  PubMed  Google Scholar 

  30. Mattson RH, Cramer JA, Caldwell BV, Siconolfi BC. Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology. 1984;34(9):1255–8.

    Article  CAS  PubMed  Google Scholar 

  31. Loder EW, Buse DC, Golub JR. Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review. Am J Obstet Gynecol. 2005;193(3 Pt 1):636–49.

    Article  CAS  PubMed  Google Scholar 

  32. Mosher WD, Jones J. Use of contraception in the United States: 1982–2008. Vital Health Stat 23. 2010;(29). Hyattsville, MD: National Center for Health Statistics.

    Google Scholar 

  33. Nelson AL, Cwiak C. Combined oral contraceptives. In: Hatcher RA, Trusseull J, Nelson AL, Cates W, Kowal D, Policar MS, editors. Contraceptive technology. New York: Ardent Media, Inc.; 2011. p. 249–341.

    Google Scholar 

  34. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd ed. Cephalalgia. 2004;24 Suppl 1:9–160.

    Google Scholar 

  35. Edelman A, Gallo MF, Nichols MD, Jensen JT, Schulz KF, Grimes DA. Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials. Hum Reprod. 2006;21(3):573–8.

    Article  CAS  PubMed  Google Scholar 

  36. MacGregor EA, Hackshaw A. Prevention of migraine in the pill-free interval of combined oral contraceptives: a double-blind, placebo-controlled pilot study using natural oestrogen supplements. J Fam Plann Reprod Health Care. 2002;28(1):27–31.

    Article  PubMed  Google Scholar 

  37. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, on behalf of the AMP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–9.

    Article  CAS  PubMed  Google Scholar 

  38. Stewart WF, Wood C, Reed ML, Roy J, Lipton RB, AMPP Advisory Group. Cumulative lifetime migraine incidence in women and men. Cephalalgia. 2008;28(11):1170–8.

    Article  CAS  PubMed  Google Scholar 

  39. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol. 2005;106(3):509–16.

    Article  PubMed  Google Scholar 

  40. Kittner SJ, Stern BJ, Feeser BR, Hebel R, Nagey DA, Buchholz DW, et al. Pregnancy and the risk of stroke. N Engl J Med. 1996;335(11):768.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. MacGregor EA. Migraine and use of combined hormonal contraceptives: a clinical review. J Fam Plann Reprod Health Care. 2007;33:159–69.

    Article  PubMed  Google Scholar 

  42. Pathan M, Kittner SJ. Pregnancy and stroke. Curr Neurol Neurosci Rep. 2003;3(1):27–31.

    Article  PubMed  Google Scholar 

  43. Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, et al. Prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5(12):1424–9.

    Article  PubMed  Google Scholar 

  44. Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK, Tekkis PP. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007;56(6):830–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Nguyen GC, Boudreau H, Harris ML, Maxwell CV. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol. 2009;7(3):329–34.

    Article  PubMed  Google Scholar 

  46. Buchwald H, Oien DM. Metabolic/bariatric surgery Worldwide 2008. Obes Surg. 2009;19(12):1605–11.

    Article  PubMed  Google Scholar 

  47. Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294(15):1909–17.

    Article  CAS  PubMed  Google Scholar 

  48. Society of Family Planning. Contraceptive considerations in obese women. Contraception. 2009;80:583–90.

    Article  Google Scholar 

  49. American College of Obstetricians and Gynecologists. Bariatric surgery and pregnancy, ACOG practice bulletin no. 105. Obstet Gynecol. 2009;113(6):1405–13.

    Article  Google Scholar 

  50. Teitelman M, Grotegut CA, Williams NN, Lewis JD. The impact of bariatric surgery on menstrual patterns. Obes Surg. 2006;16(11):1457–63.

    Article  PubMed  Google Scholar 

  51. Ledoux S, Msika S, Moussa F, Larger E, Boudou P, Salomon L, et al. Comparison of nutritional consequences of conventional therapy of obesity, adjustable gastric banding, and gastric bypass. Obes Surg. 2006;16(8):1041–9.

    Article  PubMed  Google Scholar 

  52. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis—United States, 2007. MMWR Surveill Summ. 2009;58(3):1.

    PubMed  Google Scholar 

  53. Di Martino V, Lebray P, Myers RP, Pannier E, Paradis V, Charlotte F, et al. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology. 2004;40(6):1426–33.

    Article  PubMed  Google Scholar 

  54. Libbrecht L, Craninx M, Nevens F, Desmet V, Roskams T. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology. 2001;39(1):66–73.

    Article  CAS  PubMed  Google Scholar 

  55. American Diabetes Association. Position statement. Standards of medical care in diabetes—2012. Diabetes Care. 2012;35 Suppl 1:S11–63.

    Google Scholar 

  56. Schwarz EB, Postlethwaite D, Hung YY, Lantzman E, Armstrong MA, Horberg MA. Provision of contraceptive services to women with diabetes mellitus. J Gen Intern Med. 2012;27(2):196–201.

    Google Scholar 

  57. May AL, Kuklina EV, Yoon PW. Prevalence of cardiovascular disease risk factors among US adolescents, 1999–2008. Pediatrics. 2012;129:1035–41.

    Article  PubMed  Google Scholar 

  58. Lopez LM, Grimes DA, Chen-Mok M, Westhoff C, Edelman A, Helmerhorst FM. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev. 2009;(7):CD008452.

    Google Scholar 

  59. Beasley A, Estes C, Guerrero J, Westhoff C. The effect of obesity and low-dose oral contraceptives on carbohydrate and lipid metabolism. Contraception. 2012;85(5):446–52.

    Article  CAS  PubMed  Google Scholar 

  60. Halperin IJ, Kumar SS, Stroup DF, Laredo SE. The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies. Hum Reprod. 2011;26(1):191–201.

    Article  CAS  PubMed  Google Scholar 

  61. Kahn HS, Curtis KM, Marchbanks PA. Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk. Diabetes Care. 2003;26(1):216–25.

    Article  CAS  PubMed  Google Scholar 

  62. Mastrandrea LD, Wactawski-Wende J, Donahue RP, Hovey KM, Clark A, Quattrin T. Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care. 2008;31(9):1729–35.

    Article  PubMed Central  PubMed  Google Scholar 

  63. Ward MM. Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey. J Womens Health. 2004;13(6):713–8.

    Article  Google Scholar 

  64. Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum. 2007;56(6):2092–4.

    Article  PubMed Central  PubMed  Google Scholar 

  65. Culwell KR, Curtis KM, del Carmen Cravioto M. Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review. Obstet Gynecol. 2009;114(2 Pt 1):341–53.

    Article  PubMed  Google Scholar 

  66. Culwell KR, Curtis KM. Contraception for women with systemic lupus erythematosus. J Fam Plann Reprod Health Care. 2013;39:9–11.

    Article  PubMed  Google Scholar 

  67. Yanni E, Grosse SD, Yang QH, Olney RS. Trends in pediatric sickle cell disease-related mortality in the United States, 1983–2002. J Pediatr. 2009;154(4):541–5.

    Article  PubMed  Google Scholar 

  68. Legardy JK, Curtis KM. Progestogen-only contraceptive use among women with sickle cell anemia: a systematic review. Contraception. 2006;73(2):195–204.

    Article  PubMed  Google Scholar 

  69. Manchikanti Gomez A, Grimes DA, Lopez LM, Schulz KF. Steroid hormones for contraception in women with sickle cell disease. Cochrane Database Syst Rev. 2007;(2):CD006261.

    Google Scholar 

  70. Haddad LB, Curtis KM, Legardy-Williams JK, Cwiak C, Jamieson DJ. Contraception for individuals with sickle cell disease: a systematic review of the literature. Contraception. 2012;85(6):527–37.

    Google Scholar 

  71. de Abood M, de Castillo Z, Guerrero F, Espino M, Austin KL. Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients. Contraception. 1997;56(5):313–6.

    Article  PubMed  Google Scholar 

  72. De Ceulaer K, Gruber C, Hayes R, Serjeant GR. Medroxyprogesterone acetate and homozygous sickle-cell disease. Lancet. 1982;2:229–31.

    Article  PubMed  Google Scholar 

  73. Nascimento Mde L, Ladipo OA, Coutinho EM. Nomegestrol acetate contraceptive implant use by women with sickle cell disease. Clin Pharmacol Ther. 1998;64(4):433–8.

    Article  PubMed  Google Scholar 

  74. Howard RJ, Lillis C, Tuck SM. Contraceptives, counselling, and pregnancy in women with sickle cell disease. BMJ. 1993;306(6894):1735–7.

    Google Scholar 

  75. Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000;84:160–74.

    CAS  PubMed  Google Scholar 

  76. Kessler RC, Walters EE. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety. 1998;7(1):3–14.

    CAS  PubMed  Google Scholar 

  77. Kessler RC, Berglund P, Demler O, Jin R, Marikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;(62):593–602. Erratum in Arch Gen Psychiatry. 2005;(62):768.

    Google Scholar 

  78. Davalos DB, Yadon CA, Tregellas HC. Untreated prenatal maternal depression and the potential risks to offspring: a review. Arch Womens Ment Health. 2012;15:1–14.

    Article  PubMed  Google Scholar 

  79. Kotch JB. Maternal and child health: programs, problems, and policy in public health. 2nd ed. Sudbury, MA: Jones and Bartlett; 2005.

    Google Scholar 

  80. Mohllajee AP, Curtis KM, Morrow B, Marchbanks PA. Pregnancy intention and its relationship to birth and maternal outcomes. Obstet Gynecol. 2007;109:678–86.

    Article  CAS  PubMed  Google Scholar 

  81. Shah PS, Balkhair T, Ohlsson A, Beyene J, Scott F, Frick C. Intention to become pregnant and low birth weight and preterm birth: a systematic review. Matern Child Health J. 2011;15:205–16.

    Article  PubMed  Google Scholar 

  82. Civic D, Scholes D, Ichikawa L, LaCroix AZ, Yoshida CK, Ott SM, et al. Depressive symptoms in users and non-users of depot medroxyprogesterone acetate. Contraception. 2000;61(6):385–90.

    Article  CAS  PubMed  Google Scholar 

  83. Westhoff C, Truman C, Kalmuss D, Cushman L, Davidson A, Rulin M, et al. Depressive symptoms and Depo-Provera®. Contraception. 1998;57(4):237–40.

    Article  CAS  PubMed  Google Scholar 

  84. Berenson AB, Odom SD, Breitkopf CR, Rahman M. Physiologic and psychologic symptoms associated with use of injectable contraception and 20 μg oral contraceptive pills. Am J Obstet Gynecol. 2008;199(4):351.e1–12.

    Article  Google Scholar 

  85. Bartz D, Goldberg AB. Injectable contraceptives. In: Hatcher RA, Trusseull J, Nelson AL, Cates W, Kowal D, Policar MS, editors. Contraceptive technology. New York: Ardent Media, Inc.; 2011. p. 209–36.

    Google Scholar 

  86. Neumark-Sztainer D, Wall M, Larson NI, Eisenberg ME, Loth K. Dieting and disordered eating behaviors from adolescence to young adulthood: findings from a 10-year longitudinal study. J Am Diet Assoc. 2011;111(7):1004–11.

    Article  PubMed Central  PubMed  Google Scholar 

  87. Pasternak Y, Weintraub AY, Shoham-Vardi I, Sergienko R, Guez J, Wiznitzer A, et al. Obstetric and perinatal outcomes in women with eating disorders. J Womens Health. 2012;21(1):61–5.

    Article  Google Scholar 

  88. Pinkerton JV, Guico-Pabia CJ, Taylor HS. Menstrual cycle-related exacerbation of disease. Am J Obstet Gynecol. 2010;202(3):221–31.

    Article  PubMed Central  PubMed  Google Scholar 

  89. DiVasta AD, Feldman HA, Giancaterino C, Rosen CJ, LeBoff MS, Gordon CM. The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa. Metabolism. 2012;61:1010–20.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  90. Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab. 2002;87:2883–91.

    Article  CAS  PubMed  Google Scholar 

  91. Scholes D, Lacroix A, Ichikawa L, Barlow W, Ott S. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med. 2005;159:139–44.

    Article  PubMed  Google Scholar 

  92. World Health Organization. Statement on hormonal contraception and bone health. Wkly Epidemiol Rec. 2005;80:302–4.

    Google Scholar 

  93. Lopez LM, Grimes DA, Schulz KF, Curtis KM. Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev. 2011;(7):CD006033.

    Google Scholar 

  94. Godart NT, Perdereau F, Rein Z, Berthoz S, Wallier J, Jeammet P, et al. Comorbidity studies of eating disorders and mood disorders: critical review of the literature. J Affect Disord. 2007;97:37–49.

    Article  CAS  PubMed  Google Scholar 

  95. Karceski S. Initial treatment of epilepsy in adults. UpToDate; 2013. [Updated 30 November 2012; cited 5 February 2013]. Available from: http://www.uptodate.com.

  96. Christensen J, Petrenaite V, Atterman J, Sidenius P, Ohman I, Tomson T, et al. Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial. Epilepsia. 2007;48(3):484.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA, 02115, USA

    Elizabeth Janiak M.A., M.Sc. & Deborah Bartz M.D., M.P.H.

Authors
  1. Elizabeth Janiak M.A., M.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deborah Bartz M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Deborah Bartz M.D., M.P.H. .

Editor information

Editors and Affiliations

  1. Dept. of Obstetrics and Gynecology Section of Family Planning and Contraceptive Research, The University of Chicago, Chicago, Illinois, USA

    Amy Whitaker

  2. Dept. of Obstetrics and Gynecology Section of Family Planning and Contraceptive Research, The University of Chicago, Chicago, Illinois, USA

    Melissa Gilliam

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Janiak, E., Bartz, D. (2014). Adolescents with Medical Illness. In: Whitaker, A., Gilliam, M. (eds) Contraception for Adolescent and Young Adult Women. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6579-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6579-9_9

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6578-2

  • Online ISBN: 978-1-4614-6579-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation